We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$3.11M
2
XOM icon
ExxonMobil
XOM
+$2.53M
3
IMGN
Immunogen Inc
IMGN
+$2.22M
4
CVX icon
Chevron
CVX
+$2.06M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBR.A icon
251
Petrobras Class A
PBR.A
$107B
$1.31M 0.07%
105,921
+6,607
+7% +$72K
ED icon
252
Consolidated Edison
ED
$41.6B
$1.3M 0.07%
14,425
-1,689
-10% -$161K
CI icon
253
Cigna
CI
$76.6B
$1.3M 0.07%
4,639
+70
+2% +$18.2K
PEG icon
254
Public Service Enterprise Group
PEG
$39.8B
$1.3M 0.07%
20,771
-1,895
-8% -$118K
MS icon
255
Morgan Stanley
MS
$337B
$1.3M 0.07%
15,198
-305
-2% -$26.1K
ROIV icon
256
Roivant Sciences
ROIV
$25.2B
$1.29M 0.07%
127,878
-7,703
-6% -$68.9K
ZNTL icon
257
Zentalis Pharmaceuticals
ZNTL
$308M
$1.28M 0.07%
45,531
+6,643
+17% +$159K
ECL icon
258
Ecolab
ECL
$75.6B
$1.28M 0.07%
6,867
+347
+5% +$59.7K
GFI icon
259
Gold Fields
GFI
$29.2B
$1.27M 0.07%
92,126
+3,216
+4% +$48.9K
SNDX icon
260
Syndax Pharmaceuticals
SNDX
$1.84B
$1.27M 0.07%
60,841
+8,236
+16% +$171K
ZTO icon
261
ZTO Express
ZTO
$18.2B
$1.27M 0.07%
50,770
-9,913
-16% -$273K
ARDX icon
262
Ardelyx
ARDX
$1.24B
$1.27M 0.07%
374,831
+93,420
+33% +$383K
CLDX icon
263
Celldex Therapeutics
CLDX
$2.77B
$1.27M 0.07%
37,421
+10,049
+37% +$339K
DOW icon
264
Dow Inc
DOW
$21.6B
$1.27M 0.07%
23,812
+955
+4% +$50.8K
JNPR
265
DELISTED
Juniper Networks
JNPR
$1.27M 0.07%
40,432
+5,616
+16% +$173K
BEKE icon
266
KE Holdings
BEKE
$16.8B
$1.26M 0.07%
85,068
-9,265
-10% -$151K
LMT icon
267
Lockheed Martin
LMT
$134B
$1.25M 0.07%
2,705
+198
+8% +$91.9K
BCRX icon
268
BioCryst Pharmaceuticals
BCRX
$2.37B
$1.25M 0.07%
176,892
+24,138
+16% +$194K
SNAP icon
269
Snap
SNAP
$7.32B
$1.23M 0.07%
103,853
+15,139
+17% +$152K
CTRA
270
DELISTED
Coterra Energy
CTRA
$1.22M 0.07%
48,305
-7,289
-13% -$181K
IMGN
271
DELISTED
Immunogen Inc
IMGN
$1.22M 0.07%
64,715
-188,111
-74% -$2.22M
BSX icon
272
Boston Scientific
BSX
$65.8B
$1.22M 0.07%
22,566
+629
+3% +$32.9K
DBX icon
273
Dropbox
DBX
$6.81B
$1.21M 0.07%
45,551
+9,583
+27% +$218K
TRV icon
274
Travelers Companies
TRV
$80.8B
$1.21M 0.06%
6,963
-148
-2% -$26.1K
BLK icon
275
Blackrock
BLK
$164B
$1.21M 0.06%
1,748
-28
-2% -$18.8K
9 10
11
12 13

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.